These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 828260)

  • 1. [Certain biochemical mechanisms of suppression of vital activity of Mycobacterium tuberculosis under the effect of acridines].
    Promyshlianskiĭ AM
    Probl Tuberk; 1976 Nov; (11):80-5. PubMed ID: 828260
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of acridine compounds on stopping the development of drug resistance in Mycobacterium tuberculosis (an experimental study)].
    Efremova IIa; Il'ina TB; Vishnevskiĭ BI; Vavilin GI
    Probl Tuberk; 1977 Sep; (9):61-4. PubMed ID: 411125
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of acridine compounds on the development of drug resistance to antitubercular agents of Mycobacterium of avian type].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1969 Apr; 14(4):355-8. PubMed ID: 4977641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increasing the antibacterial action of antitubercular agents through the use of acridine derivatives].
    Solov'ev VN; Zueva VS; Pavlov EP
    Probl Tuberk; 1969; 47(1):83-7. PubMed ID: 4985625
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
    Fattorini L; Gennaro R; Zanetti M; Tan D; Brunori L; Giannoni F; Pardini M; Orefici G
    Peptides; 2004 Jul; 25(7):1075-7. PubMed ID: 15245864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of penicillin and penicillin with hydrazines on Mycobacterium tuberculosis in vitro].
    Tybusz R; Dettlaff Z
    Gruzlica; 1966 Jul; 34(7):627-9. PubMed ID: 4959114
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
    Karakousis PC; Williams EP; Bishai WR
    J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence, not resistance, is the cause of loss of isoniazid effect.
    Wallis RS; Palaci M; Eisenach K
    J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M; Gutierrez J; González J; Ruiz P
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potentiating the specific activity of isoniazid and streptomycin by benzimidazole derivatives].
    Vishnevskiĭ BI
    Probl Tuberk; 1987; (2):58-61. PubMed ID: 3106955
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective effects of nitrofuraldoxime-anti on isoniazid resistant m. tuberculosis.
    Wayne LG; Russell RL
    Scand J Respir Dis; 1966; 47(1):18-26. PubMed ID: 4958046
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of antituberculosis-drug action by acridines.
    Soloviev VN; Zueva VS
    Lancet; 1968 Aug; 2(7564):412. PubMed ID: 4173816
    [No Abstract]   [Full Text] [Related]  

  • 15. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
    Shkurupií VA; Kurunov IN; Arkhipov SA
    Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculostatic effect in the joint of isoniazid and streptomycin with dimexide and 5-fluorouracil in vitro].
    Khazina TI; Dolzhanskiĭ VM; Cherednichenko LP
    Probl Tuberk; 1980 Jan; (1):63-6. PubMed ID: 6768064
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.